To better care for pregnant and postpartum mothers with ADHD, clinicians should understand the unique facets of ADHD in women, how symptoms change during pregnancy and the postpartum period, and how to help new parents make decisions around medication use and ADHD symptom management.
Modafinil (brand name Provigil) and armodafinil (Nuvigil) are wake-promoting agents used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea. They are also used in other settings, often in [...]
ADHD is an important risk factor for both depression and anxiety disorders in the postpartum period and should be considered in the post-pregnancy maternal care.
Prenatal exposure to benzodiazepines and Z-hypnotics was not associated with increased risk of ADHD in exposed children.
The findings of this study do not suggest that prenatal antipsychotics exposure is associated with increased risk for ADHD, ASD, small for gestational age, or preterm birth.
We continue to see an increasing number of women with attention-deficit/hyperactivity disorder (ADHD) who are either pregnant or planning to conceive. While we have considerable data to indicate that women with mood and anxiety [...]
As soon as we published this article on the use of modafinil during pregnancy, another study was published which included data on the reproductive safety of modafinil and armodafinil from the US Provigil/Nuvigil Pregnancy [...]
According to a report published by the CDC in Morbidity and Mortality Weekly Report (MMWR), the use of stimulant medications for the treatment of attention-deficit/hyperactivity disorder (ADHD)Â by reproductive-age women is on the rise. In [...]
Previous studies have demonstrated that children born to mothers who smoke during pregnancy are at increased risk for attention-deficit/hyperactivity disorder (ADHD). Â In a recent review, Huang and colleagues looked at data from 15 cohort studies [...]
 According to a report published by the CDC in Morbidity and Mortality Weekly Report (MMWR), the use of stimulant medications for the treatment of attention-deficit/hyperactivity disorder (ADHD)  by reproductive-age women is on the rise. [...]
